Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 320 participants.
Also called NCT07499154
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 320 participants
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Registry
-
NCT07499154
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07499154. Randomized; quadruple masking; primary purpose prevention. Start 2026-04-01 (anticipated); primary completion 2027-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
- Acronym
- PLICS
- Condition
- Congenital Heart Disease
- Condition
- Postoperative Pulmonary Complications
- Condition
- Acute Lung Injury
- Intervention (Drug)
- Lidocaine %2 ampoule
- Intervention (Drug)
- Normal Saline (0.9% NaCl)
- Lead sponsor
- The Children's Hospital of Zhejiang University School of Medicine
Record details
- Record id
cardio:ct-nct07499154- Content hash
c63a4be390b8276d33dfa22b3f6230c50179ff6270f924a38e0be0c94a5be2db